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ABSTRACT

Human embryonic stem cells (hESC) and induced pluripotent stem cells

(iPSC) provide a model for studying paradigms of early human development
Techniques that quantify transcriptional activity, protein expression and
chromatin modification as hESC and hiPSC differentiate can be used to decipher

the changes that are responsible for specification and development of cellular
lineages. This thesis presents an optimized protocol to induce and isolate

primordial germ cells (PGC) from hESC and hiPSC, Time-course experiments

revealed that bone morphogenetic protein (BMP) signals play an essential role in
inducing BL1MP1-expressing PGC from both hESC and hiPSC. Magnetic

activated cell sorting for cell surface marker CXCR-4 allowed the isolation of cells
with PGC gene expression profiles. PCR and genetic manipulation was used to
determine the specific variance of BLIMP1, a transcriptional repressor, which
initiates PGC identity. We identified BLIMPIa as the variance responsible for the

activation of a restricted PGC fate and repression of the somatic cell program.
The expression of BLIMP1 was shown to directly target pluripotency gene OCT4.

Furthermore, a novel function for BL1MP1 during epigenetic reprogramming of
the germline is presented. Expression of BLIMP1 was significantly correlated with
histone modification, specifically the occurrence of histone 3 lysine 27

trimethylation.
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CHAPTER ONE
INTRODUCTION

Pluripotent Stem Cell Models

A pivotal advance concerning human development and disease has been

the discovery of human pluripotent stem cells. Pluripotent describes any
population of cells which undergo mitotic division to form self-renewing daughter
cells, which maintain the capacity to differentiate to mature cells types of all three
germ layers (Weissman et al., 2001). Pluripotent cells can be compared to other

stem cells types; totipotent cells can form an entire organism including
extraembryonic tissues, multipotent cells form several cell types but are more

limited in lineage differentiation, and unipotent cells only differentiate into a single
cell type.

The most common source of human pluripotent cells are from the inner

cell mass (ICM) of a five-to-eight day human blastocyst. Human embryonic stem
cells (hESC) were first isolated from donated in vitro fertilized (IVF) eggs. The

ICM of preimplantation stage embryos were isolated and initially grown in culture

with the support of mouse fibroblast feeder layers (Thompson et al., 1998a).
Potency of the ICM-harvested cells was established by comparing morphology,
telomerase activity, pluripotency-associated gene expression, and differentiation
capacity for derivatives from all three germ layers; determined in previous non

1

human primate embryonic stem cell foundational studies (Thompson et al., 1995 ;
Thompson et al, 1998b).

Given ethical concerns regarding the destruction of preimplantation stage
human embryos adult derived populations of pluripotent stem cells were sought

out. The goal was to voluntarily isolate adult tissues and then genetically

manipulated them in order to re-establish the pluripotency. Accordingly, these
cells would not only be harvested from an ethical source but could also serve as

therapeutically autologous cells for transplantation. By over-expressing
pluripotency-associated genes, highly expressed in hESC, adult cells were

demonstrated to be induced to regress to a pluripotent state. Genetically

manipulated adult derived pluripotent cells are known as human induced
pluripotent stem cells (hiPSC). The most prominent protocol for deriving hiPSC

involves retroviral reprogramming of adult fibroblast cells to promote the
expression of ESC specific transcription factors: OCT4, Sox2, KLF4 and c-MYC

(Takahashi et al., 2007). These specific transcription factors were selected from
24 candidate genes that regulate the ESC identity and were evaluated for their

ability to reprogram somatic cells (Takahashi et al., 2006). Given the hiPSC
reprogramming protocol, a readily available and ethically acceptable source (i.e.
not an embryonic cell source) of pluripotent cells was defined.
The derivation hESC and hiPSC has opened up an entirely novel field in which

human development and disease, previously restricted to animal modeling, can
be readily manipulated.
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In the past modeling of molecular and cellular level processes have been
restricted to animal model systems. While animal models have contributed to our

understanding of important developmental processes that relate to human

development there are several drawbacks to this approach. Animal models can
only be used to accurately study processes that are evolutionarily conserved and

even then subtle but significant differences exist. For example in the field of stem
cell biology several major distinctions exist between two commonly compared

species, human and mouse. Human ICM are harvested from the preimplantation
blastocyst, a characteristic that enables ethical harvesting. Comparative analysis

of hESC to both preimplantation mouse embryonic stem cells (mESC) and
mouse postimplantation epiblast-derived stem cells (mEpiSC) revealed that
EpiSC share gene expression patterns and respond to signals similarly to hESC
(Tesar et al., 2007). Also, hESC and mESC and mEpiSC share expression of

several cell surface markers including stage specific embryonic antigens three
(SSEA3) and four (SSEA4), cell surface expression of SSEA1 is associated with

differentiation in hESC compared to pluripotency in mESC and EpiSC

(Henderson et al., 2002). However, mESC and mEpiSC are both distinct from
hESC in the expression of cell surface marker stage specific embryonic antigen 1

(SSEA1). Furthermore, the two species differ regarding molecular mechanisms

of self-renewal. Maintenance of self-renewal in mESC relies on the presence of
leukemia inhibitory factor (LIF) which binds the leukemia inhibitory factor receptor

(LIFR). Consequently, activation of LIFR by LIF initiates a molecular cascade
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involving signal transducer and activator of transcription 3 (STAT3). On the other
hand, it has been demonstrated that STAT3 signaling pathways are not activated

in human embryonic stem cells (hESC) to regulate self-renewal and therefore do

not require LIF in culture medium (Daheron et al., 2004). The aforementioned
paradigms highlight the importance of examining development and disease in
human models, in addition to foundational studies in other animal model

systems.
Once the pluripotent cells, hESC or hiPSC, are derived, they possess

unlimited potential for researching any cell type of the human anatomy including
significant precursors of ectoderm, mesoderm, endoderm and germline lineages

(Figure 1). Cell culture of pluripotent cells coupled with molecular biology
techniques have been used extensively to study previously impenetrable lineage

development in order to elucidate the underlying molecular mechanisms of
differentiation from derivatives of all three germ layers: endoderm, mesoderm

and ectoderm (Wang etal., 2011; Xu et al., 2012; Sasaki et al., 2010).
Furthermore, hESC and hiPSC have important implications in disease

modeling. Potentially, hiPSC specifically reprogrammed from adult cells collected
from the tissue of an individual with a diseased phenotype could be readily used

to model and interrogate the development of the disease in vitro. The practice

4

Ectoderm derived
Neurons

Mesoderm derived
Cardiomyocytes

Endoderm derived
Adipose

Germ Line

Figure 1. Overview of Pluripotency. Pluripotent cells
must have a low cytoplasm to nucleus ratio, with
prominent nuclei. The cells must be capable of
mitotic self-renewal and the ability to differentiate
into, all three germ layers, as well as germ cells.
Scale bars are 50pm. (Aw TJ, Haas SJ, Liew D,
Krum H. 2005. Meta-analysis of Cyclooxygenase-2
Inhibitors and Their Effects on Blood Pressure. Arch
Intern Med 165:490-496.)

of collecting tissues from diseased individuals and reprogramming those cells
into hiPSC has become well known as the “disease in a dish” model. Diseased
hiPSC can be manipulated to delineate underlying mechanisms of the disease

and its development. Cardiac diseases, related to several DNA variations, have
been described, but the effects of these variations are not known (Kathiresan et
al., 2009). Thus hiPSC from patients with cardiac disease can be used to

determine the underlying mechanism of the DNA variations and their progression

to the diseased phenotype. Similarly, patient specific hiPSC have also been
proposed as a source of cells to clinically combat degenerative diseases. For

example, hiPSC used to generate dopaminergic neurons have the potential to
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cure idiopathic Parkinson’s disease (Soldner et al., 2009). The disease in a dish

model has also become widespread in laboratories focusing on drug discovery,
and is being used in parallel with animal-based drug testing. For example, BGP-

15, a pharmacological inducer of heat shock protein 72 was recently used by
disease in a dish modeling to reduce the progression of Duchenne muscular

dystrophy (Gehrig, 2012).

Primordial Germ Cell Differentiation

This work addresses a highly unique and understudied lineage of

consequence, the germline. Germ cells arise from a niche located in the proximal
posterior epiblast, which enables the cells to avoid signaling factors from the
primitive streak (Wylie, 2000). Signaling from the surrounding somatic niches

leads to the expression of the transcriptional regulator of the germline, Blymphocyte maturation protein 1 (BL1MP1) (Ohinata etal., 2005). BLIMP1

expression initiates specification of primordial germ cells (PGC). Following the
onset of specification, the cells undergo mitosis and begin migration across the

genital ridges. The cells will continue to replicate as well as upregulate germ cell

transcripts (Kurimoto et al., 2008). Ultimately, PGC colonize the gonads and

mature into haploid gametes (Tam et al., 1981).
Germ cells are distinguishable from all other somatic lineages and

undergo several unique processes. Development of somatic cell types requires
switching from a pluripotent identity to a differentiated state, as indicated by
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coincident differentiation following OCT4 knockdown (Hay et al., 2004). As germ

cells differentiate, their survival is dependent upon the maintenance of OCT4
(Kehler et al., 2004), which is unsurprising given the characteristic pluripotent

designation of the germline. The maintenance of pluripotency as germ cells

differentiate is highly unique. Given the unique model of pluripotency it has been

proposed that exploring the development and formation of the germline can help
explain how adult stem cells niches maintain self-renewal and a multipotent
differentiation potential (Lanza, 2009). In fact, multipotent adult stem cell niches

have been identified in several tissues, including epidermal, follicular, intestinal,
neuronal, and hematopoietic niches (Fuchs and Segre, 2000).
Germline modeling also provides the opportunity to study reprogramming

of the epigenome. Epigenetics involves the regulation of gene transcription
without affecting the deoxyribose nucleic acid (DNA) sequence itself. The
heritability of the correct epigenetic code from parent to offspring is pivotal and

requires thorough examination. Alteration of the normal epigenome can result in
major degenerative diseases, like cancer, Angelman's syndrome, Beckwith-

Wiedemann syndrome and Prader-Willi syndrome. Epigenetic therapies aim to

inhibit epigenetic modifiers in order to regulate chromatin accessibility. While the
epigenetic enzymes targeted in these therapies are determined based on
germ line epigenetic reprogramming, there are few studies that focus on

molecular mechanisms that initiate reprogramming in the germ cells. (Egger et
al., 2004).
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Research of germline development will also contribute to therapeutic
efforts to combat infertility. Every year 12 couples out of 10,000 struggle with

infertility (Hull et al., 1985). Depicting the stage specific molecular interactions

involved in the differentiation of human germ cells provides a tool for
interrogating and ameliorating qualitative and quantitative causes of infertility.
Ultimate goals of describing germ line differentiation can also be used to optimize

protocols for deriving germ cells in vitro from patient specific hiPSC.

Research Aims

Currently there is a minimal amount of research on the human germline,
and moreover on the specification of human primordial germ cells (PCG). The
germline is especially difficult to study given the ethical constraints of harvesting
embryonic germ cells from human embryos, as well as the prohibition of genetic

manipulation of human embryos, preventing examination of key developmental
genes in human. Using hESC and hiPSC, the molecular mechanisms of germline

specification were examined using murine model paradigms. This thesis
describes the following aims concerning germ line specification:

1) Efficient induction and isolation of PGC
2) Determining the specific transcriptional regulator of the germline
3) Observing early epigenetic changes of the germline

8

Efficient Induction and Isolation of Primordial Germ Ceils
Relatively little is known about specific pathways that control PGC

commitment in early human embryonic development and the hESC model, but it
is becoming evident that specific pathways may differ substantially between
mouse and human development. One example of non-evolutionarily conserved

molecular mechanisms across mice and humans involves BMP4. BMP4 has

been extensively used to maintain the mouse stem cell phenotype. Conversely,

blocking BMP4 signaling along with addition of bFGF to hESC cultures has been
demonstrated to suppress differentiation and maintain pluripotency in hESC (Xu

et al., 2005). Furthermore, BMP signaling in human embryos has been
associated with the bone differentiation and hematopoiesis (Chadwick et al.,
2003; Cheng et al., 2003). Additionally, negative regulation of BMP signaling has
been used to restrict differentiation to specific lineages. The addition of Noggin to
differentiating hECS antagonizes BMP signaling and is used to induce the

differentiation of neuronal precursors (Gerrard et al., 2005). More recently a small
molecule BMP antagonist dorsomorphin has also been shown to block BMP

signaling and has been used to promote cardiomyogenesis (Hao et al., 2008).

The primary goal of this work is to elucidate the role of BMP on germ cell

formation in hESC and hiPSC. We hypothesized that BMP4 would be required
for PGC formation in both hESC and hiPSC. Additionally, we wanted to examine
the effect of co-induction with other BMP signaling factors, such as BMP7 and

BMP8 on PGC formation; given synergistic effects demonstrated in mice models.
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We also explored the effect of increasing the most significant signaling factor
identified in our induction treatments, also called a boost treatment (Goldman et

al, 2009). The goal of using boost treatments was to enhance PGC induction

efficiencies. In order to quantitatively evaluate the efficiency of PGC induction
following BMP treatments and identify the most significant factor for boost

treatments, a time-course experiment was performed using the following BMP
treatments in HES media without bFGF:
1) BMP4

2) BMP7
3) BMP8
4) BMP4and BMP7

5) BMP4 and BMP8
6) BMP7 and BMP8
7) BMP4, BMP7 and BMP8.
The time-course evaluated the expression of BLIMP 1 following four and

five days of BMP treatment. The experiment was also used to determine the

timepoint for the initiation of BLIMP 1 expression following BMP treatment It
additionally provided data for quantitative analysis to determine if co-induction of

BMPs is significantly more effective than unaccompanied BMP treatments.
Quantitative data was gathered by determining the percentage of cells
expressing BLIMP1 as well as real-time Q-PCR to determine relative gene
expression levels specifically expressed in PGC.
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The inhibition of BMP signals on the expression of BLIMP1 while all other

culture conditions are kept constant was also evaluated. The small signaling
molecule dorsomorphin (DM) was added to differentiation media subjected to the

induction pressures of BMP treatments. Immunocytochemistry was used to
determine if inhibition of BMP signals, by receptor antagonist dorsomorphin
interrupts the activation of BLIMP1 and ultimately the PGC fate.
Once the highest efficiency induction strategy for deriving PGC was
determined, research aimed to define a reliable method of collecting PGC from

the heterogeneous cultures. Several cells surface markers of PGC have been

described, including cluster of differentiation 117 (CD177), C-X-C chemokine

receptor type 4 (CXCR-4), and stage specific embryonic antigen 1 (SSEA1)
(Xiang-long et al., 2005; Geijsen et al., 2004; Molyneaux et al., 2003; Knaut et
al., 2000). Precision identification of PGC by cell surface markers was pivotal to

isolation studies and contributed in the determination of an optimal protocol for
derivation and isolation of PGC from pluripotent cultures.

Determining the Specific Transcriptional Regulator of the Germline

Mouse studies have served as an archetype for identifying genes
specifically expressed in the germline; this is because very few studies examine

human germline formation. Dynamic global gene expression of PGC identified
PGC+/ESC- germ cell markers TNAP, BL1MP1, Stella and Fragillis (Sabour et al.,

2011; Ohinata, 2005). BLIMP1 is the paradigm marker for early identification of
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PGC and has been functionally characterized as the transcriptional regulator of
the germline (Figure 2).

BLIMP1 expression is critical for the formation of PGC, acting as a

transcriptional regulator for the initiation of the germline (Ohinata 2009; Kurimoto,
2008; Ohinata, 2005; Vincent, 2005). Repression of somatic genes, especially

the HOX gene cluster, is highly associated with BL1MP1 expression. Repression
of the HOX cluster is important to preventing mesoderm differentiation,
experienced by PGC somatic neighbors. BLIMP 1 deficient PGC are not capable

of repressing the somatic program, which abruptly halts PGC specification. To a
lesser extent, BLIMP1 impairment leads to lower expression levels of PGC
specific genes (Kurimoto et al., 2008). Following BLIMP1 expression, PGC

should initiate the expression of Stella and Fragillis and maintain pluripotency

gene expression of OCT4, Sox2, Nanos3 and Nanog (Ohinata et al., 2009).
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Proximal Epiblast

ElimpT repressed somatic program
aadatiivates germ eeiliranscnpts

HoxaiS HoxbT expression
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I
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Somatic Cel! Fate

Figure 2. Primordial Germ Cell Specifieation Program. BLIMP1
expression, following BMP signaling, is responsible for somatic program
repression, upregulation of other PGC markers and complete epigenetic
reprogramming.

There are two major variances of BL1MP1 that have been identified. The
full-length transcript, BLIMPla, has been associated with normal'function in B-:
lymphocytes but the shorter variance, BLIMPIb, has been related to B-cell

oncogenesis. Given the correlation of BLIMPIb expression and oncogenesis,

BLIMP 1a was hypothesized to be the variance responsible for the transcriptional
regulation in early PGC formation. The effects of BLIMP1 variances during hESC

and hiPSC differentiation were analyzed in order to study the effects of BLIMPla
and BLIMPIb. Once BMP treatments were confirmed to induce PGC
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specification, transcripts of BMP-induced cultures were probed for the expression

of BLIMPIa and BLIMPIb. Additionally, a Tet-On transfection system was
utilized to promote the over-expression of each variance for comparative

analysis. The effect of BLIMP 1 variance over-expression was determined using
real-time Q-PCR and single cell real-time Q-PCR.
Observing Early Epigenetic Changes in the Germline
Studies concerned with the dynamics of epigenetic reprogramming in the

mouse germline have identified two significant changes of histone protein 3 that

occur in concert with genome-wide DNA demethylation. Epigenetic
reprogramming is postulated to be essential for the reacquisition of totipotency

during germline formation, and removal of the previously established epigenetic

memory. (Seki et al., 2007; Seki et al., 2005)

Research will focus on the changes in histone 3 lysine markers during
germ cell differentiation in hESC and hiPSC. Given the significance of epigenetic

reprogramming during germline formation, it is expected that the patterns of

histone modification demonstrated in mice will be evolutionarily conserved in
human germ cells. In order to establish the changes in histone methylation
markers of interest, immunocytochemistry analysis was performed on

undifferentiated pluripotent cells, spontaneously differentiating cells and PGC-

induced cells.
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CHAPTER TWO
LITERATURE REVIEW

The Germline
The germline is a significant lineage, responsible for the propagation of

the parental genome to subsequent generations. Primordial germ cells (PGC) are

the founder population of the germline (Figure 3).

Figure 3. OCT4-Enhanced Green
Fluorescent Protein Primordial Germ
Cells. Migrating along the genital
ridge of day 12 mouse embryo.
(Courtesy of Duncan Liew,)
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Of the more than two hundred cell types described in the human body,
germ cells are the only cell type that undergoes meiosis in order to produce

haploid cells for sexual reproduction. The germline has been referred to as the

one of the few cell types capable of achieving totipotency (Mitalipov et al, 2009).
PGC in the developing embryo will mature into gametes, which fuse in sexual

reproduction to form a zygote. The zygote will divide and develop to form every
cell of the new organism including the germ cells as well as supportive

extraembryonic tissues.
Early PGC are difficult to discriminate from hESC due to the co-expression

of pluripotency markers such as alkaline phosphatase (ALP) and OCT4

(Ginsburg, 1990; Yeom et al., 1996). However, as normal embryonic
development continues hESC begin to differentiate into somatic cell lineages and
only the germ line will continue to express OCT4 and maintain pluripotency

(Yeom, 1996). The avoidance of somatic lineage differentiation and maintenance
of pluripotency during germ cell development provides a unique developmental

model.
Theories of Germ line Specification

In 1885, Weismann postulated that germline specification occurs as a
result of determinants passed down from the previous generation (Weismann et

al, 1885), Later known as preformation, asymmetrical localization of maternally
inherited determinants is responsible for designating germline cells, this mode of
germ cell specification holds for model organisms such as Caenorhabditis
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elegans, Drosophila melanogaster, Xenopus laevis, and Danio rerio (Wylie,

2000; Eddy, 1978).
However, attempts to identify preformation determinants in mammalian
oocytes demonstrated that the preformation mode of germ cell specification is

not ubiquitous (Eddy et al, 1981). In the majority of metazoans and all mammals,

the germ cell specification mode utilized is called epigenesis. During epigenesis
naive cells, capable of differentiating into either germ cells or mesoderm

lineages, will be restricted to the germline by signaling molecules received from
neighboring cells (Extavour et ak, 2003; Johnson et al., 2003).

Germ Cell Formation

Germ cell formation can be divided into four main stages (Figure 4):
1) Specification
2) Migration

3) Colonization
4) Maturation
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Stages of Germ Cell Formation
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]

PGC specification
PGC migration
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Transcription factors during PGC differentiation
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Figure 4. An Overview of Primordial Germ Cell Formation. Major
stages include specification, migration, colonization, and
development. The development stage occurs during prenatal and
postnatal timepoints. Patterns pre-meiotic of gene expression, are
below each stage. (Courtesy of Dn Duncan Liew, University California
Riverside Stem Cell Core)

Specification. The mouse model has been the archetype for determining

molecular interactions within the mammalian embryo that result in the
specification of PGC, the founding population of the germline. Extensive in vivo

studies of mouse embryonic development have led to the following mammalian

paradigm of germ cell formation. During embryonic development, a group of
cells proximal to the primitive streak elude normal somatic programming during
early gastrulation (Lanza, 2009). The cells are located within the posterior

epiblast, and receive molecular signaling from surrounding mesoderm cells.
Bone morphogenetic proteins (BMPs) have been identified to be the critical factor
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to induce PGC formation in the early mouse embryo (Dudley et al., 2010; Lawson
et al., 1999). BMP signals initiate a cascade of molecular interactions that
produce germ cells (de Sousa Lopes, 2004; Toyooka et al., 2003;). Furthermore,
BMP signaling has been demonstrated to result in the expression of the master
regulator of the germline, B-lymphocyte maturation protein 1 (BLIMP1) (Ohinata,

.
2009)

Migration. The onset of BLIMP 1 expression initiates transcriptional
changes which repress the somatic cell program and upregulate germ cell genes

(Kurimoto, 2008; Ohinata 2005). PGC were first identified as an alkaline

phosphatase (ALP)-expressing niche within the proximal, posterior epiblast. The
pre-migratory primordial germ cells will begin to proliferate and continue to grow

in cell number until the niche has grown by 10-fold. At this point PGC will mature

to migratory PGC and emerge from the extraembryonic mesoderm (Lawson,
1994; Ginsburg et al., 1990). Migratory PGC will propagate and mature during

migration though the primitive hindgut and dorsal mysentery. Survival and proper
migration rely on the regulation by CXCR-4 signaling (Molyneaux et al., 2003).
Colonization. Migratory PGC further mature into post-migratory germ cells

shortly after entering the genital ridges of the gonads (Tam and Snow, 1981).
Once germ cells have colonized the gonads the presence of the Sry gene

encoded on the Y sex chromosome will determine the sexual identity of the germ
cells. (Lanza, 2009)
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Maturation. In the genital ridges the germ cells will revert to a pre-meiotic

cell cycle, and initiate meiosis via retinoic acid signaling from the adjacent
mesonephros. The expression of the Sry gene product will curb male germ cells

from the default meiotic pathway experienced by female germ cells. Female
germ cells experience permanent mitotic arrest prior to birth and enter prophase I

shortly after, meiotic female germ cells pause during diplotene stage of Prophase
I and await menarche for continued meiosis. Conversely, male germ cells enter

G1/G0 mitotic arrest, and Sry downstream targets inhibit meiosis and promote
support from surrounding somatic Sertoli cells. After birth prespermatagonia will

begin spermatogenesis and await meiosis following puberty. (Lanza, 2009)
Bone Morphogenetic Protein Signaling as a Mechanism to Promote Primordial

Germ Cell Specification

BMP signaling in the mouse embryo has been identified as an essential
requirement of inducing the expression of BLIMP1, an early PGC marker

(Ohinata, 2009). In 2009, Ohinata demonstrated that BMP4 alone is capable of
inducing germ-like cells from the developing epiblast mouse. Gene knockout
studies demonstrated that BMP4 initiates BLIMP 1 transcription through

transforming growth factor beta (TGFb) signaling.

BMP, a member of the TGFb superfamily, will initiate an intracellular
cascade that works in combination with another TGFb cascade, which is highly
active and initiated by activin. BMP signaling is initiated by BMP ligand binding to

a heterodimer receptor complex (Figure 5). The receptor complex consists of two
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constitutively active type II receptor subunits and two type I receptor subunits

which are actively recruited by the ligand. The activated receptors of TGFb
signaling: will possess serine/threonine kinase activity, which will initiate

phosphorylation cascades (Itman et al, 2006).

Figure 5. Transforming Growth Factor Beta Signaling by Smad Proteins.
BMP4 binds to BMP receptors which activate the formation of a smad
protein complex, co-localization permits nuclear translocation and
subsequent transcriptional modification. (Itman et al., 2006).

Accordingly, extracellular binding of BMP4 ligand to constitutively active
activin receptor-like kinase (ALK) 1/6 will be followed by the recruitment of the
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bone morphogenetic protein receptor II (BMPR1I) dimer, forming the complete
heterdimer complex. BMP4 binding of the heterodimer complex will initiate

intracellular kinase activity which will phosphorylate receptor activated-smads (R-

Smads) 1, 5 and 8. The activated R-Smads will associate with co-Smad4, which

has a nuclear localization sequence. Accordingly, the BMP ligand initiated
signaling is translocated to the nucleus to promote the transcription of BLIMP1.

Thus, prevailing evidence supports the role of BMP4 as the ligand initiator of

BLIMP1 expression and PGC specification. (Ohinata et al., 2009)
The effect of BMPs that are structurally heterogeneous from BMP4 has

also been previously examined. Co-localized expression of BMP4 and BMP8 has
been demonstrated in the murine model. Although BMP4 initiates the expression

of BLIMP1 through TGFb type receptors, BMP8 does not directly affect BLIMP1

expression as it doesn’t act via TGFb signaling. However, BMP8 does play a
role in counteracting inhibitory signals that act to prevent germ cell specification.

Thus the synergistic effects of BMP4 in concert with other BMP signals has been
documented (Ohinata et al, 2009).

Function of B-Lymphocyte Induce Maturation Protein 1 During Primordial Germ
Cell Specification

BLIMP1 has been well documented as a transcriptional regulator directing

the repression of promoter regions. As a transcriptional repressor the function of
BLIMP1 in several cell lineages is to restrict differentiation to a specific cell type.

In retinal differentiation BLIMP1 prevents bipolar cell fate and accordingly
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promotes the differentiation of photoreceptor cells (Brzezinski et al., 2010).

During epidermal multipotent stem cell commitment the expression of BLIMP1
promotes sebaceous gland progenitors with self-renewing characteristics

(Horsley et al, 2006). BLIMP1 was first identified in B-lymphocyte maturation
(Gyory et al., 2003). Thus it is apparent that BLIMP1 can perform many roles as
a transcriptional repressor and affects the differentiation of several cell types,
when expression occurs during the appropriate windows of time. Previously
discussed expression-windows of BLIMP1 occur during late stages of cell lineage

differentiation. However, when BLIMP1 expression is initiated in naive
uncommitted cells in the early mouse embryo, BLIMP1 will direct hESC toward

the germline.
BL1MP1 belongs to the positive regulatory domain zinc finger (PRDM)

protein family of transcriptional repressors, characterized by positive regulatory

and zinc finger binding domains. Like other PRDM genes, BLIMP1 (PRDM1)
transcription can results in the expression of two distinct variances, BLIMPIa and

BLIMPIb. The gene sequence possesses two ATG transcription start sites
(Figure 6). The BLIMPIa transcript consists of seven exons, which encode the
full-length 798 amino acid protein. Alternatively, a novel transcription start site for

BLIMPIb is located 155 base pairs upstream of the fourth exon. Thus BLIMPIb
will only encode the last four exons of BLIMPIa and the resulting protein consists

of 697 amino acids. Accordingly, the variances share a common carboxyl
terminus and differ in their amino-terminus. Loss of the first 101 amino acids of
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the full length BLIMPIa protein disrupts the function of the positive regulatory
domain of the BLIMPIb. (Gyory et al., 2003)
Comparative examination into the roles of these variances in B-

lymphocyte differentiation has revealed an important distinction between the two

variances of BLIMP1. Myeloma and transformed cell lines undergoing Blymphocyte differentiation expressed high levels of BLIMPIb. Conversely,
BLIMPIa was determined to be prominent and highly expressed in normal B-

lymphocyte maturation (Gyory et al., 2003); The identification of the primary

variances responsible for the functional role in PGC specification remains to be
elucidated.
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■Figure 6. B-Lymphocyte Induced Maturation Protein! Variance
Exon Map. The variances result from two ATG transcriptional
start sites and:result in protein product of different amino acid:
lengths. BLIMPIa is a 798 amino acid protein, and BLIMPIb is
a 697 amino acid protein.
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Epigenetic Properties of Germ Cells
Epigenetic erasure is a hallmark of PGC formation, and a pathway that is
unique compared to all other somatic cell lineages. Epigenetic patterns

determine the accessibility of specific regions of DNA, providing variations in
cellular phenotypes. DNA accessibility Is determined by the status of the

chromatin. Changes in chromatin conformation will cause changes in the

transcriptional state of the DNA structure. Chromatin can be modified in two
ways, the DNA sequence can be modified or the histone proteins which the DNA

wraps around can be modified. DNA can be methylated in order to directly
silence genes. Furthermore, DNA can be indirectly silenced by further
condensing DNA around histone proteins. The histone code is the modified

conformation of histone proteins, which can be modified by protein subunit
interchange and amino acid methylation, deacetylation, ubiquitylation or
sumoylation. Heterochromatin is associated with a non-transcriptionally active

DNA, whereas euchromatin is transcriptionally active. Germ cells must initiate the
erasure of the aforementioned epigenetic changes prior to gamete formation so

that the zygote will be free of epigenetic marks. Germ line epigenetic

reprogramming permits the reestablishment of totipotency. Additionally,
epigenetic reprogramming removes genomic imprinting, or parent specific

silencing of particular genes, so haploid gametes can establish new imprinting
patterns following fertilization. (Lanza, 2009)
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Mouse modeling has been used to describe the epigenetic changes of the
developing mammalian embryo, given the consequences of improper epigenetic
reprogramming the patterns of these changes should be evolutionarily

.

conserved. Mouse studies have identified two significant histone methylation
patterns that correlate with genome-wide DNA demethylation (Seki et al., 2007;

Seki et al.,:2005). Modification of histone 3 via dimethylation of lysine 9

(H3K9me2) and the trirfietylation of lysine 27 (H3K27me3) are methylation marks
that undergo changes dependent on germ cell maturation. Epigenetic

reprogramming was proposed to occur progressively as PGC begin to migrate,
as observed by the downregulation of H3K9me2 and concomitant upregulation of

H3K27me3 (Figure 7).
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Figure 7. Germ line Epigenetic Reprogramming Patterns in Mice.
Specification is initiated by the expression of BLIMR1, after which other
germline genes like Stella are upregulated. Epigenetic reprogramming
involves genome-wide DNA demethylation by DNA methyltransferases, like
DMNT1. Two histone 3 modifications associated with DNMT1 expression are
the repression of histone 3 lysine 9 dimethylation (H3k9me2) and the
upregulation of hisone 3 lysine 27 trimethylation (H3K27me3).
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Derivation Of Germ Cells From Human Pluripotent Stem Cells
Haploid gametes have been derived from male and female mESC albeit at

very low efficiency (Kehler et al., 2005). Spontaneous differentiation enabled by
embryoid body (EB) formation was the method primarily utilized to induce
germline formation to sperm and oocyte (Geijsen et al., 2004; Hubner et al.,

.
2003)
Improving upon foundational mouse research by formulating induction and

isolation strategies has enhanced efforts to derive and manipulate functioning
human germ cells in vitro. The primary approach to deriving human germline in

vitro focuses on isolation at specific stages of germ cell formation. Accordingly,

several cell surface markers of the germline have been described and used to
isolate germ cells (Xiang-long et al., 2005; Geijsen et al., 2004; Knaut et al.,
2003; Molyneaux et al., 2003). A therapeutic goal of human germline studies is to
derive patient specific gametes for millions world-wide who suffer from infertility.

Toward this effort, human meiosis has been recently achieved in vitro by long
term differentiation of heterogeneous cultures, but their efficiency and

functionality remains to be fully investigated (Eguizabal et al., 2011).
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CHAPTER THREE
METHODOLOGY

Culture Techniques
Culture of hESC and hiPSC

To maintain hESC and hiPC cultures, H9 hESC and Riv9 hiPSC were
plated into BD Falcon polytene tissue culture treated plastic which has been
additionally coated with Geltrex (1:100; Invitrogen). H9 hESC and Riv9 hiPSCs
were fed serum-free defined mTeSRI media (Stem Cell Technologies)

containing 100 ng/ml basic fibroblastic growth factor (bFGF) daily and maintained
in an environment of 5% CO2 at 37°C. Cells were passaged every five to seven
days when they had reached 80-90% confluency. Cells were split using accutase

(Innovative Cell Technologies Inc.) and mechanical disaggregation with 3 mm

glass beads (Fisher Brand) followed by dilution and collection using Dulbecco’s

modified eagle medium (DMEM).

Differentiation of Primordial Germ Cells from hESC and hiPSC Cultures
PGC differentiation was initiated when cells were 50-80% confluent. On

day zero of BMP induction experiments the daily media was changed to human
embryonic stem cell (HES) media without bFGF. HES media stock contained 400
ml knockout DMEM (Invitrogen), 100 ml knockout serum replacement (KOSR)

(Invitrogen), 5 ml 1X glutamax, 5 ml non-essential amino acid solution (NEAA),
14 pl 2-B-mercaptoethanol (BME) + basic fibroblastic growth factor (bFGF). HES
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media without bFGF was supplemented with BMP signaling factors. Based on
preliminary data BMP4 was supplemented at a higher concentration in
subsequent experiments, 100 pg/ml; compared to BMP7 and BMP8

supplemented at a concentration of 50 pg/ml.
Magnetic Activated Cell Sorting of Primordial Germ Cells

Differentiated BMP-induced PGC were treated with rho kinase inhibitor
(Rl), washed with PBS and trypsinized with 0.25% EDTA Trypsin (Life

Technologies). Cell pellets were then resuspended in 500 pl cold Magnetic
activated cell sorting (MACS) buffer (Miltenyi Biotec) and cell surface antibody,

CD117, CXCR4 or SSEA1 at appropriate dilutions (Table 1). Cells were then

stained for one hour at 4°C. Cells were washed and resusupended in 500 pl

MACS buffer and incubated an additional hour with magnetic beads specific to
primary antibodies. Prior to MACS by the Auto MACS Pro (Miltenyi Biotec), the

magnetic columns were changed and cells were washed and resuspended in 3
ml of cold MACS buffer. Positive and negative cell fractions for CD 117, CXCR4

or SSEA1 were then collected into labeled 15 ml conical tubes using the
Possel_s MACS isolation protocol. Cell pellets from positive and negative

fractions were spun down and stored at -80°C for subsequent molecular biology.
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Table 1 .Primary Antibody
Antibody
BLIMP1
Oct-4
CXCX-4
CD117
SSEA1
H3K9me2
H3K27me3

Dilutions
Dilution Ratio
1:200
1:100
1:10
10 pl / 1,000 cells
1:100
1:100
1:250

Supplier
Cell Signal
Santa Cruz
R & D Systems
Millipore
Millipore
Novus Biologicals
Millipore

Molecular Biology
RNA Extraction and Reverse Transcription

After cell pellets were isolated from a sample they were stored at -80°C
prior to RNA extraction. Once thawed, the cell pellet was lysed and RNA

extracted according to the Bio-Rad RNA extraction kit (Bio-Rad). The
concentration of the RNA was measured using an Epoch micro-plate

spectrophotometer and Take3 micro-spot plate (BioTek). The first-strand cDNA

synthesis was accomplished by using the iScript cDNA Synthesis kit (BioRad),
after which reverse transcription polymerase chain reaction (RT-PCR) was used

to amplify the cDNA. Each RT-PCR reaction consisted of PCR master mix,
sample cDNA and 1 pl each of both the forward and reverse primers of genes of
interest (Table 2). RT-PCR amplifications were initiated at 95°C for 5 minutes

(mins) followed by annealing and extension.
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Table 2. Real Time-I
Gene

BLIMPIa
BLIMP1 b

BLIMP14

ACTIN b

Chain Reaction Oligonucleotide Primers
Reverse Sequence
Forward Sequence
(5-3’)
(5-3’)
CAT GGA GGATGC
AGT GGT GGA GGA
TGG AAT GG
GGATATGAC
GGAAAG ATCTAT
AGT GGT GGA GGA
TGG AAT GG
TCC AGA
CTC CCAAAG TGC
AACAAACACATG
TGG GAT TA
CGA GTC CA
ATC TGG CAC CAC
CGT CAT ACT CCT
GCT TGC TGA TCC
ACC TTC TAC AAT
ACA TCT GC
GAG CTG CG

Real-Time Quantitative Polymerase Chain Reaction

Real-time Q-PCR was performed using a 384-well real-time thermocycler
(BioRad), and samples were repeated in duplicate. Each reaction consisted of
2.5 pl IQ Supermix (BioRad), 0.25 pl gene specific Taqman probes (Applied

Biosystems) (Table 2), 1.25 pl distilled water and 1 pl diluted cDNA (standardized
based on housekeeping gene controls). PCR amplifications were initiated at

95°C for 10 mins followed by 42 cycles of 95°C for 15 seconds and 60°C for 60
seconds. The Real-time Q-PCR data were analyzed using the comparative Ct

method.
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Table 3. Taqman Probes for Real-Time Quantitative-Polymerase Chain
Reaction
Gene
Accession Number
Assay ID

ACTIN B

NM 001101.3

Hs 99999903_m1

GAPDH

NM 002046.3

Hs99999905_m1

18S

18s_consensus.0

Hs99999901_s1

BLIMP1

NM 001198.3:

Hs00153357_m1

NM 182907.1

OCT4

NM 001173531.1

01895061_m1

NANOG

NM 024865.2

Hs02387400_g1

VASA

NM 001142549.1

Hs00987125_m1

STELLA

NM 199286.2

Hs01931905_g1

DAZL

NM 001190811.1

Hs00154760_m1

KIT

NM 000222.2

Hs00174029_m1

BRACHYURY

NM 003181.2

Hs00610080_m1

CDX2

NM 001265.3

Hs01078080_m1

SOX 17

NM 022454.3

Hs00751752_s1

GSC

NM 173849.2

Hs00418279_m1

HOXB1

NM 002144.3

00157973„m1
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Single Cell Real-Time Quantitative Polymerase Chain Reaction

Cells for single-cell real-time Q-PCR were sorted directly into a 9 pl lysis
solution plus 1 pl DNAase (Ambion) in a tissue culture treated flat bottom 96 well

plate (BD falcon). Cell lysis was stopped after 5 minutes by the addition of 1 pl of
stop solution (Ambion). Total cell lysate was then directly added to 4.5 pl VILO
RT master mix (Ambion), containing 3 pl of VILO RT mix and 1.5 pl SuperScript

RT enzyme. PCR amplifications were initiated at 25°C for 10 mins followed by of
42°C for 60 mins and 85°C for 5 mins. Single cell real-time Q-PCR data were

analyzed using the comparative Cy method.
Immunocytochemistry

Cells were washed twice with phosphate buffered saline (PBS) without
calcium or magnesium, and then fixed with 4% paraformaldehyde for 10-15

minutes. The cells were subsequently blocked using an antibody staining solution
(ASS) of 99% PBS without Ca2+ or Mg2+11 % goat serum and 0.1 % triton-X,
Primary antibodies were diluted (Table 1) in ASS and were incubated overnight

at 4°C. The following day primary antibodies in ASS were removed and the cells
were washed twice with ASS. Next the secondary antibodies (diluted at a ratio of
1:500 in ASS) were added and left to incubate at 25°C in the dark. Following
secondary staining the cells were again washed twice with ASS followed by one
PBS without calcium or magnesium rinse. Finally the cells were mounted with

glycerol and Vectashield mounting medium with DAP I (Vector Labs), and
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subsequently imaged using a Nikon Ti Eclipse microscope and N1S3.2 Elements
software.

Genetic Manipulation
Plasmid Preparation

Transformation of competent Escherichia coli (Invitrogen) was
accomplished by thawing competent cells stored at -80°C. Once thawed 1-5 pl of
plasmid (pCAG-rtTA, pTRE-BUMP1a, pTRE-BLIMP1b, or pTRE-GFP) was

added to the competent cells, mixed, and incubated on ice for 20 minutes.

Competent cells were then heat shocked at45°C for 1 minute and immediately

placed on ice again for two minutes. Competent cells that had taken up the
plasmids were then cultured in 1 ml of ampicillin-containing Terrific broth (AMPTB) (Invitrogen) for one hour. The bacteria were then streaked using plastic loops

onto agar containing AMP (invitrogen) in Petri dishes and stored in an
environment of 5% CO2 at 37°C for 24 hours.
Single bacterial colonies were isolated for culture and grown in AMP-TB in

suspension at 220 rpm and 37 °C; 8 hours in 5 ml culture, and then transferred to

200 ml culture for 16-18 hours. Following bacterial suspension culture, cell
pellets were collected by centrifugation at 3,500 rpm at 4°C for 30 minutes. The
cell pellets were then frozen at -20°C. Plasmids (pCAG-rtTA, pTRE-BLIMP1a,
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pTRE-BLIMP1b, or pTRE-GFP) were isolated from the bacterial pellets using the

Pure Yield Maxiprep system (Promega).

Nucleofection
hESC were transfected with a Tet-On system using co-nucleofection.

Cells were treated with rock inhibitor (Rl) at a concentration of 10 pg/ml for at
least one hour prior to nucleofection to prevent cell death. Cells were then

washed with PBS without calcium and magnesium and then disassociated into

single cells using 0.25% trypsin/EDTA (Invitrogen). Cells were collected in MEF

media (450 ml DMEM, 50 ml fetal calf serum (FCS), 5 ml 1X glutamax, 5 ml
NEAA, and 5 ml 1X sodium pyruvate) and centrifuged at 800 rpm for 3 minutes.
Each cell pellet was resuspended in 100 pl of pre-warmed human stem cell

nucleofector solution 1 (Lonza) and transferred into a nucleofector cuvette. Then,

1 pg of expression vector pCAG-rtTA and 20 pg of one of the bi-directional

response vectors pTRE-BLIMP1a, pTRE-BLIMP1b, or pTRE-GFP was added to
the cells in human stem cell nucleofector solution 1. The cuvette was then

swirled and taped twice on a hard surface before being placed into the cuvette
holder of the Lonza Amaxa Nucleofector II Device. Nucleofection program B-16
was run to introduce the plasmids to the cells’ nucleus. Following nucleofection,

cells were removed from the nucleofector cuvette and placed in a 1.5 ml

Eppendorf tube containing 1 ml of pre-warmed conditioned HES media with
bFGF supplemented with Rl to prevent further cell death. Cells in conditioned
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HES media were incubated in 5% C02 at 37°C for 10 minutes after which they
were plated drop-wise onto irradiated mouse feeders. (Chatterjee, 2011)

Clones that were successfully nucleofected were selected based on

puromyocin resistance genes in the plasmids over a period of two to four weeks.
Once colonies were capable of surviving in antibiotic selection at a ratio of

1:1000 they were picked. Colonies were manually picked using a 200 pl pipette
and split into two wells of a 24 wells plate, one of which was immediately induced

by the addition of doxycycline (Dox). Following 24-hour Dox induction the Nikon

Ti Eclipse microscope was used to confirm stable transfection.
Induction of B-Lymphocyte Induced Maturation Proteinl Variances
hESC expressing either BLIMPIa or BLIMPIb were fed serum-free

defined mTeSRI media (Stem Cell Technologies) containing 100ng/ml bFGF
daily and maintained in an environment of 5% CO2 at 37°C. When cells were

70% confluent the media was changes to HES without bFGF and the Tet-On

system was induced by adding Dox (1:1000). Cells were induced to express
either BLIMPIa or BLIMPIb for one day, after which cells were disassociated

using accutase and mechanical disaggregation with 3mm glass beads followed
by dilution and collection using DM EM. Cell pellets were stored at -80°C for RNA

extraction, RT-PCR and real-time Q-PCR analysis. The Tet-On overexpression
of BLIMPIa and BLIMPIb was also induced for three days, after which
fluorescent activated cell sorting (FACS) was used to isolate single cells for

single cell real-time Q-PCR.
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Fluorescent Activated Cell Sorting

Prior to delivering cells to the FACS technician cultures were: washed with
PBS without calcium or magnesium, then disassociated into single cells using

0.25% trypsin/EDTA. Following inactivation with MEF media cells were
centrifuged at 800 rpm for 3 min. The cell pellet was resuspended in 500 pl PBS
+ 0.1% fetal bovine serum (FBS) and kept on ice until the sample was sorted.

Once sorted, the positive and negative cell fractions were collected separately

and RNA was immediately extracted.

I mage-J Analysis
Image-J was used to analyze data in two ways. The cell counter function

was used to quantify the immunocytochemistry images taken with the Nikon Ti

Eclipse on the 10X magnification. The counter keeps track of each cell clicked in

an image, so that the number of cells expressing a protein of interest is
quantified.

Additionally, Image-J intensity function was used to quantify the
expression intensity of 10X magnification images taken with the Nikon Ti Eclipse.

With this function the expression level of two different proteins, for which

immunocytochemistry had been perform, could be compared to establish
correlation patterns.
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Statistical Data

Experiments were carried out in duplicate culture wells which contained an
average of 500,000 cells. Quantitative data is presented as standard deviation
from mean values. Statistical significance was determined by Student’s t-test with

p<0.05 as a threshold for significance.
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CHAPTER FOUR

RESULTS

Bone Morphogenetic Protein4 Induced Primordial Germ Cell
Specification From Human Pluripotent Stem Cells

Time-course examination was performed to determine the timepoint
following BMP treatment that resulted in PGC induction, as determined by
expression of master regulator BLIMP1. Additionally, time-course examination

was designed to determine whether co-induction of BMP signals exert synergistic

effects on PGC formation. Similarly the time course quantitatively compared
multiple BMP co-induction efficiencies to determine the best induction strategy

for PGC specification. In order to measure and analyze the induction of PGC
formation both H9 hESC and Riv9 hiPSC were grown to 70% confluence and

then changed from daily mTeSR media to HES differentiation media

supplemented with 50 pg/ml BMP. Treatments included BMP4; BMP7; BMP8;
BMP4 & 7; BMP4 & 8; BMP7 & 8; and BMP4, 7 & 8.
Following one, three, and five days of differentiation the H9 hESC and
Riv9 hiPSC were fixed for immunocytochemistry analysis of pluripotency marker

OCT4 and PGC specific BLIMP1 protein expression (Figures 8, 9 and 10).

BLIMP1 was not expressed following one day of BMP induction. Similarly,
immunocytochemistry analysis also revealed that three days of BMP induction
was not sufficient to induce BL1MP1 expression. BLIMP1 expression was

detected after five days of BMP treatment.
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Figure 8. Day Three Immunocytochemistry Analysis of H9 hESC Bone
Morphogenetic Protein Treatments. (A) Immunocytochemistry
analysis of BMP4, BMP7 and BMP8-treated H9. BLIMP1 expression
was not detected. (B) Co-induction using BMP4 & 7, BMP4 & 8,
BMP7 & 8, and BMP4, 7 & 8 also did not appear to promote BLIMP1
expression; pri day three. Representative images taken at 10X. Scale
bar = 50; microns.
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Figure 9. Day Five Immunocytochemistry Analysis of H9 hESG Bone
Morphogenetic Protein Treatments. (Aj Immunocytochemistry
analysis of BMP4, BMP7 and BMP8 treated H9 hESC cultures
revealed that BMP4 treatment alone was sufficient to induce BLIMP1
expression. (B) In co-treatmeht cultures, BLIMP 1 expression was
restricted to cultures differentiated in BMP4 containing media. BMP7
reduced the effect of BMP4 in the absence of:BMP8. Representative
images taken at 10X., Scale bar = 50 microns.
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Figure 10; Day Five Immunocytochemistry Analysis of Riv9 hiPSC
Bone Morphogenetic Protein Treatments. (A) Immunocytochemistry
analysis of BMP4, BMP7 and BMP8-treated Riv9 hiPSC cultures ,
revealed the presence of BLIMP 1-immunoreactive cells only when
BMP4 was added to the differentiation media. (B) BLIMP1 expression
was restricted to BMP4 containing cultures. BMP7 did not diminish the
effect of BMP4 to the same extent as H9 hESC. Similarly, to hESC
BLIMP1 expression was not detected until day five in Riv9 hiPSC.
Representative images taken at 10X. Scale bar = 50. microns.
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However, five day BMP-induced BLIMP 1 expression was restricted to BMP

treatments specifically containing BMP4. This data supports evidence from the
mouse model that BMP4 is a prerequisite for BLIMP1 expression and PGC

specification.

In order to improve the activation of BLIMP 1 expression, addition of BMP4
was increased to two fold. The boost method has been previously used to

saturate receptors and achieve higher levels of cascade activation. Comparison
of four and five day BMP treatment immunocytochemistry confirmed that

increasing the amount of BMP4 drastically increased the BLIMP1 expressing
populations in all treatments (Figure 11). Accordingly, the boost method was

used in all downstream experiments.
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Figure 11. Day Five Immunocytochemistry Analysis of Bone Morphogenetic
Protein4 Boost Treatments. Analysis revealed that when the concentration of
BMP4 was increased two-fold BLIMP1 induction was increased in both H9
hESC and Riv9 hiPSC. Representative images taken at 10X. Scale bar
equals 50 microns.

The proportion of H9 hESC and Riv9 hiPSC that expressed BLIMP1 was

quantified to determine the efficiency of PGC specification (Figure 12).
Quantification of BL1MP1 expressing H9 cells demonstrated that 5% express

BLIMP1 after four days of treatment and the proportion increased to 35% on day

five. On the other hand, BLIMP1 expression was only detected in day five
culture treatments of Riv9 hiPSC demonstrating a delay in PGC differentiation.
However, the percentage of Riv9 cells that expressed BLIMP1 was higher at the

onset of protein expression on day five compared to H9; 48% in BMP4

44

treatments and 39% in BMP4, 7 and 8 treatments. Additionally, we found that:
BMP4 and co-induction of BMP4, 7 & 8 gave rise to significantly higher
percentages of BLIMPI-positive cells in both hESC and hiPSC cultures.

Figure 12. Quantification of B-Lymphocytejnduced Maturation
Proteinl-Expressing Cells Derived from’hESC and hiPSCIn the
Presence of Different Bone Morphogenetic Proteins. Data were
collected by direct scoring for cells showing BLlMPl staining
normalized to the total-cell number in a 4X image capture,
indicated by DAP I nuclear staining.

The real-time Q-PCR analysis reflected at least a 50% downregulation of

OCT4 expression levels on: day four, which continued to decrease on day five in

both hESC and hiPSC. DAZL and CD117 expression was also reduced in PGC
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compared to hESC and hiPSC. As predicted there was a significant upregulation
of BLIMP1 following BMP treatment PGC related transcripts Stella and VASA
were also upregulated in PGC compared undifferentiated cells, however

expression levels did not differ significantly between day four and day five
timepoints. Sox17, an early PGC transcript, was also upregulated in the hESCderived and hiPSC-derived PGC. (Figure 13 and Figure 14)

Furthermore, to demonstrate the relationship between BMP signaling and

the initiation of BLIMP1 expression, BMP receptors were inhibited.
Dorsomorphin, a molecular antagonist of BMP receptors, was added to the

differentiation media with the BMP treatments. Following five days of

differentiation in the presence of BMP treatment and dorsomorphin, expression

of BLIMP1 was diminished (Figure 15).
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Figure 13. Real-Time Quantitative-Polymerase Chain Reaction
Analysis of H9 hESC Following Four and Five Days of Bone
Morphogenetic Protein Treatments. Relative transcript expression
levels of three pluripotency genes, OCT4, DAZL and CD117.
Normalized data presented as mean+SEM.
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Figure 14. Real-Time Quantitative-Polymerase Chain Reaction
Analysis of Riv9 hiPSC Following Four and Five Days of Bone
Morphogenetic Protein Treatments. Relative transcript expression
levels of three pluripotency genes, OCT4, DAZL and CD117.
Normalized data presented as mean+SEM.
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Figure 15. Dorsomorphin Inhibited Bone Morphogenetic Protein
Signaling. H9 hESC and Riv 9 hiPSC cultured in the presence of
dorsomorphin significantly diminished the expression of BLIMP1.
Representative images taken at 10X. Scale bar = 50 microns.
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Surface Marker CXCR-4 Isolates PGC From Heterogeneous Populations
Magnetic activated cell sorting (MACS) was performed to characterize cell

fractions based on the expression of cell surface proteins. Antibodies previously
demonstrated to identify PGC were used to sort cells accordingly. Real-time Q-

PCR analysis was used to create a transcription profile of the cell isolated based
on the expression of CD117, CXCR-4 and SSEA1 (Figure 16). The expression

profiles revealed that CXCR-4 positive hESC and hiPSC cells highly upregulate
PGC associated transcripts, SOX17, BLIMP1, NANOG and DAZL. By
comparison SSEA1 positive cell sorting only isolated hiPSC-derived PGC, the
hESC SSEA1 positive cells did not show upregulation of PGC transcripts.

Furthermore, CD117 positive sorting isolated cells expressing somatic transcript,
such as HOXB1.
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Figure 1.6. Heat Map of .CD 117, CXCR4 and SSEA1 Cell Fractions Isolated
by Magnetic Activated C£li Sorting. CXCR-4 expressing hESC and iPSC
upregulated PGC associated genes BLIMP1, NANOG and DAZL. A similar
expression pattern was observed in SSEA1 expressing cells but to a lesser
extent. Conversely, CD117 expressing cells upregulated a conflicting set of
genes.
. .
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B-Lymphocyte Maturation Protein 1a Restricted hESC To
Primordial Germ Cell Differentiation
Amino terminus specific primers for BLIMPIa and BLIMPIb were used to
determine which variance is responsible for the transcriptional regulation of PGC

specification. Cell pellets were collected from four and five day BMP-treated

cultures and semi-quantitative PCR was performed to identify BLIMP1 variance.
Our data revealed that BLIMPIa was upregulated in all BMP-induced PGC

populations whereas BLIMPIb was not detected in any cells. However, another
PRDM transcript BLIMP14 was restricted to hESC (Figure 17).

D4 BMP

D5 BMP

BLIMPIa

BLIMPIb

BLIMP14

350 bp

ACTS

838 bp

Figure 17. Semi-Quantitative Polymerase Chain Reaction Analysis of
B-Lymphocyte Induced Maturation Protein 1 Variance Expression.
PCR of BMP-treated and undifferentiated hESC cDNAs was
performed using BLIMPIa and BLIMPIb specific forward primers.
BL1MP14, a proposed upstream gene of BLIMP1, was only
expressed in hESC. ACTB was used as a loading control and water
as a RT control.
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H9 hESC were induced to overexpress either BLIMPIa or BLIMPIb for

three days to demonstrate the downstream effects of transcriptional regulation by

each variance. To precisely analyze the changes at the cellular level, single cell
real-time Q-PCR was performed on BLIMPIa and BLIMPIb overexpressing cells
(Figure 18 and Figure 19). Threshold cycle (Ct) values from sets of BLIMPIa,

BLIMPIb and uninduced single cells revealed differential amplification of
transcripts from individual single cells. In general high background transcript

expression levels were observed in the uninduced cells, especially BLIMP1.
Statistical analysis revealed higher Ct values for pluripotency markers OCT4 and

cMYC in both BLIMPIa and BLIMPIb cells compared to uninduced cells.

Concerning the Ct values of OCT4 BLIMPIa maintain expression at a higher
level than BLIMPIb. Moreover, STELLA transcripts had significantly lower Ct
values in BLIMPIa and BLIMPIb single cells compared to uninduced.
Conversely, DAZL Ct values in BLIMPIa cells was significantly higher compared

to BLIMPIb and uninduced cells. Notably, HOXB1 a somatic transcript
demonstrated lower Ct values in all uninduced single cells, compared to
BLIMPIa-induced cells.
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Figure 18. Single Ceil Real-Time Quantitative-Polymerase
Chain Reaction Analysis Part 1. Single cell real-time QPCR analysis of six BLIMPIa- and BLIMPIboverexpressing cells and six uninduced counterparts. Ct
values for BLIMP1, OCT4, cMYC, H0XB1, DAZL, and
Stella from six replicate single cells are presented.n=6.
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Figure 19. Single Cell Real-Time QuantitativePolymerase Chain Reaction Analysis Part 2.
Statistical data comparing Ct values of BLIMP1,
OCT4, DAZL, Stella and HOXB1 from nucleofected
BLIMPIa and BLIMPIb overexpressing cells and
uninduced counterparts. n=.6-10.
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Epigenetic Role of B-Lymphocyte Induced Maturation Proteinl
The epigenetic status of hiPSC was compared to BMP4 induced PGC

using immunocytochemistry for two histone protein methylation patterns,
H3K9me2 and H3K27me3. Changes in the histone methylation are correlated
with genome-wide DNA demethylation during epigenetic reprogramming of PGC.

Based on the mouse model system H3K9me2 levels were predicted to decrease
as H3K27me3 levels were predicted to increase. Riv9 hiPSC were used as a

baseline for comparison of H3K9me2 and H3K27me3 status. Riv9 hiPSC were

determined to express both histone methylation marks (Figure 20).

The relationship between OCT4 expression of pluripotent hiPSC and
histone methylation marks was examined by quantifying the intensity levels of co

expression of OCT4 and the histone modifications (Figure 21). High expression
levels of OCT4 were observed to be correlated with high levels of H3K9me2 and
H3K27me3, correlation coefficient values of 0.591 and 0.554 respectively.
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H3K9me2
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H3K9me2/DAPI

H3K27me3.

DAPI

H3K27me3/DAPI

Figure 20. Riv9 hiPSC Histone Methylation Patterns. Riv9
hiPSC displayed ubiquitous expression of H3K9me2 and
H3K27me3.
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Figure 21. Immunocytochemistry Intensity Analysis of Histone
Methylation Patterns and OCT4. Intensity levels of protein expression
within 200 individual cells which co-expressed H3K9me2 and OCT4.
Cells co-expressing H3K27me3 and OCT4 were quantified using Image J
analysis software. Coefficients of correlation were determined, and
supported a positive relationship for the histone markers and OCT4.
n=200.
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When the pluripotent cells were spontaneously differentiated the

methylation pattern changed (Figure 22). This data demonstrates that epigenetic

profiles change as the pluripotent cells undergo in vitro differentiation.
Specifically, while pluripotent cells experienced a reduction in the occurrence of
H3K9me2, H3K27me3 levels were maintained.
BMP treatments were used to induce the PGC fate so the corresponding

epigenetic profile could be determined. As expected H3K9me2 was reduced
during PGC specification, however the levels of H3K27me3 were maintained

rather than increasing (Figure 23). To further explore the relationship between
histone methylation levels and PGC specification the intensity level of BMPinduced hESC was quantified to determine the correlation between H3K27me3

and BLIMP1 (Figure 24). The maintenance of H3K27me3 was shown to be
positively correlated with the onset of BLIMP1 expression in PGC.
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Figure 22. Spontaneously Differentiating Riv9 hiPSC Histone
Methylation Patterns. Spontaneous differentiation of Riv9 hiPSC
resulted in deviation in the pattern of occurrence of H3K9me2 among
the several cell types. Conversely, H3K27rfie3 levels were maintained.
Following five days of differentiation residual undifferentiated regions
maintained pluripotent methylation patterns (outlines in white dashes).
Images taken at 4X. Scale bar = 50 microns.

60

Figure 23. Histone Methylation Patterns of Induced Primordial Germ Cells. (A)
Loss of H3K9me2 in PGC induced cultures. As PGC induced cultures
differentiated, demonstrated by loss of 0CT4, H3K9me2 levels were reduced.
(B) Co-expression of H3K27me3 and BLIMP1. BL1MP1 positive cells
appeared to express and maintained H3K27me3 expression.
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H3K27me3

td » 9
Figure 24. Immunocytochemistry Intensity
Analysis of H3K27me3 and B-Lymphocyte
Induced Maturation Protein 1. BLIMP1 positive
cells unequivocally expressed H3K27me2.
However, BLIMP1 was weakly correlated with
the expression of H3K27me3 epigenetic
marks. n=200.
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CHAPTER FIVE

DISCUSSION

Optimized Induction and Isolation of Primordial Germ Cells

An in vitro time-course was utilized to determine optimal conditions to
induce and isolate the founding population of the germline. Derivation of a large

population of PGCs will enable wide-scale manipulation of these significant
progenitors, and improve current knowledge on the unique processes of germline

differentiation. Mouse paradigms have confirmed the significance of BMP4 as an
initiating mechanism of the germ cell fate (Lawson et al., 1999). Furthermore, co
induction of mouse models was demonstrated to improve the efficiency of PGC
induction (Ohinata et al, 2009). Our results indicate that the role of BMP signaling

during the PGC specification is evolutionarily conserved. Specifically, BMP4 is

both necessary and sufficient to induction PGC specification as indicated by the
onset of BLIMP1 expression in hESC and hiPSC. In the absence of BMP4

signaling in vitro PGC specification is not induced. Furthermore' presence of
BMP receptor antagonist, dorsomorphin, was sufficient to prevent BLIMP1

activation. Thus, a signaling cascade initiated by BMP4 leads to the activation of
germline transcriptional regulator BLIMP1 and initiates PGC specification.

Moreover, the co-induced cultures with BMP4 and 8 exhibited lower
induction efficiencies than observed in mouse models. Given the inhibitory role of

BMP8 against non-PGC signaling from neighboring somatic niches within the
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mouse embryo proper, we speculate that in vitro cultures which lack niche

organization accordingly do not benefit from BMP8 inhibition. Interestingly the
addition of BMP7, required for early PGC proliferation (Ross et al., 2007), added

to the effect of BMP4 and 8 to increase the efficiency of PGC specification. Given
the miniscule expression of BLIMP1 in BMP4 and 7 treatments it can be

assumed that interaction of BMP7 and BMP8 is required to improve the PGC
induction. Whether this interaction involves the inhibition of BMP7 by BMP8 to

promote induction is yet to be explored. Protein quantification data reflect that the
highest efficiency of BLIMP1 expression in H9 hESC was achieved following
BMP4, 7 and 8 treatment. Our immunocytochemistry data is supported by real

time Q-PCR data in which the highest relative expression levels were also

observed in the BMP4, 7 and 8 treatments. On the other hand, data for Riv9
reflects higher percentages of BLIMP 1 expressing cells in BMP4 treatments,
whereas the Q-PCR relative expression levels of BMP4 and BMP4, 7, and 8
were not significantly different. The higher percentage of BLIMP1 cells in BMP4

treatment can be related to transcription differences in the individual cells. Thus,
BMP4 cells express lower transcription levels of BLIMP1, so that a smaller

population of BMP4, 7 and 8 cells were able to achieve similar levels of BLIMP1

expression. Single cell analysis utilizing a BLIMP1 reporter line would clarify
these reports, and avoid assumptions caused by bulk culture RNA.
Based on the real-time Q-PCR data BMP signaling result is followed by

transcription of BLIMP1 by day four in both hESC and hiPSC cultures. However
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immunocytochemistry revealed that although transcripts are present in the day
four BMP-treated Riv9 ceils, protein expression is delayed until day five.

Nevertheless, immunocytochemistry and real-time Q-PCR reflected similar

transcript and protein expression levels in five day cultures achieved by the
addition of BMP4, 7 and 8. Accordingly, once cells were induced for five days

isolation was performed by MACS. MACS is a preferred method of precisely
isolating small fractions of stem cells from heterogeneous populations (Palmon et

al., 2012). Given the variable propensity of hESC and hiPSC to differentiate into
specific lineages, MACS isolation is an ideal tool for isolating PGC. Isolation of
germ cells has been previously accomplished by sorting for cell surface markers,

CD177, CXCR-4 and SSEA1 (Xiang-long et al., 2005; Geijsen et al., 2004;

Knaut et al., 2003; Molyneaux et al., 2003). Genetic profiles of CD117, CXCR-4
and SSEA1 positive and negative cell fractions were analyzed to determine

which marker would isolate our cells of interest. CXCR-4 is related to the survival
and migration of PGC (Molyneaux et al., 2003) and identified the early PGC
population of interest. The CXCR-4 positive cell genetic profile was sufficient to

characterize the cells fraction as germ-like. Accordingly, the method of five day
BMP4, 7 and 8 co-induction followed by CXCR-4 MACS isolation can be

repeatedly utilized to isolate large populations of PGC in order to interrogate
mechanisms of germ cell differentiation. Future studies will attempt to clone a
BLIMP1 reporter in order to further optimize the identification and modeling of the

germline and unique processes like epigenetic erasure and meiosis.
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B-Lymphocyte Induced Maturation Protein 1a Restricted hESC
to Germ Cell Fate
BL1MP1 has been previously identified as the regulator of the germline

(Ohinata et al., 2005). As a transcriptional repressor BLIMP1 restricts cells from
entering a somatic program and consequently promotes designation to germ cell

fate (Kurimoto et al, 2008). Identification of two well described variances of
BLIMP1, BLIMPIa and BLIMPIb, has led to debate concerning the variance

responsible for germ cell specification. BMP-induced five day cultures
differentiating to PGC were examined for the expression of BLIMPIa and

BLIMPIb. Transcripts for BLIMPIa were confirmed in every PGC induced

culture. Conversely, there was no detection of BLIMPIb in any of the BMPinduced PGC cultures. The data clearly demonstrates that BLIMPIa is

responsible for transcriptional repression of the somatic program and PGC
specification. Given the disruption of the PR domain exons in BLIMPIb (Gyory
et al., 2004), it follows that the protein domain is crucial for functionality of
BLIMPIa at the onset of germ cell differentiation.

Single cell analysis reinforced the functional role of BLIMPIa in PGC
specification. BLIMPIa expression examined at the cellular level demonstrated
expected transcriptional characteristics of PGC. Compared to uninduced

counterparts BLIMPIa cells downregulated pluripotency markers as PGC

differentiation initiated, whereas STELLA an early marker of PGC (Payer et al.,

2006) was upregulated in BLIMPIa cells. Furthermore, BLIMPIa repressed
transcription of somatic program marker HOXB1 at the single cell level.
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Significant differences in between BLIMPIa and BLIMPIb single cells
involved pluripotency-related transcripts, OCT4 and cMYC. Since BLIMPIb

expression resulted in down regulation of pluripotency genes, which must be
maintained during germline differentiation, it can be assumed that BLIMPIb is

functionally inappropriate for germline transcriptional regulation. OCT4 is known
to be a crucial to maintaining pluripotency in both hESC and the germiine (Pesce
et al., 1998; Adjaye et al., 1999; Goto et al., 1999 ). Specifically in the germline,
maintenance of 0CT4 has been associated with germ cell survival (Kehler et al.,
.
2004)
The data demonstrates a significant distinction in the level of
downregulation of OCT4 between BLIMPIa and BLIMPIb as well as a second

pluripotency marker cMYC. Consequently, BLIMPIb does not sufficiently

maintain the expression of these critical pluripotency genes and is an
inappropriate initiator of PGC specification. Alternatively, BLIMPIb may exert its

effects to induce human pluripotent stem cells to differentiate into non-germ cell

lineages.

Histone Methylation Patterns Were Evolutionarily Conserved

Routine zygotic fusion by haploid gametes necessitates reestablishment
of a totipotent identity. Achieving totipotency requires expression of pluripotent

transcripts and epigenetic erasure (Surani et al., 2007). In vivo mouse modeling

has established a pattern of epigenetic reprogramming of the germline.
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Immediately following PGC induction repressive methylation patterns responsible

for cell type specific gene expression are reduced. Specifically, as DNA is
demethylated there is a concomitant loss of H3K9me3. Following demethylation,

H3K9me2 euchromatic regions upregulate another repressive modification

H3K27me3. H3K27me3 has also been observed in the pluripotent ICM and
inactivated X-chromosomes. However, H3K27 is significantly more permissive
and thus a more appropriate modification for reestablishing totipotency. (Seki et

al., 2004).
These histone methylation marks were examined during early human

PGC differentiation to evaluate the evolutionary conformity of epigenetic
reprogramming. Prior to comparing germ cell epigenetics across species, the

histone methylation pattern of the pluripotent cells was established. The hiPSC,
like pluripotent ICM, ubiquitously expressed H3K27me3. H3K9me2 was also

expressed in hiPSC, which conflicts with expression of histone 3 lysine 9

trimethylation patterns observed in hESC (Mattout and Meshorer, 2010).
Nevertheless, these findings bolster augments that purport the designation of

hiPSC as a distinct pluripotent cell type given their source and unique epigenome
(Kim et al., 2010; Chin et al., 2009).

Following the onset of BL1MP1 expression in PGC induced cultures rapid
and unequivocal loss of H3K9me2 was confirmed. This result was distinct from
H3K9me2 patterns in spontaneously differentiating cultures, in which occurrence

of several distinct lineage gene expression patterns resulted in heterogeneous
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levels of the histone modification. Regarding H3K27me3, wide-spread

expression of the histone modification was observed in both hiPSC,

spontaneously differentiating and PGC induced cultures. While spontaneously
differentiating cell expression of H3K27me3 can be attributed to X-chromosome
inactivation (Seki et al., 2004), further examination of PGC expression of
H3K27me3 was required. Analysis of the expression intensities of BL1MP1 and

H3K27me3, which exhibited a correlation coefficient of 0.239, were not as

significant as the mouse model would suggest. One explanation for the weak
correlation could result from differences in the H3K27me3 pattern of pluripotent

precursors of the germline in mice. Also, given the wide-spread expression of

H3K27me3 and the rapid differentiation of PGC in vitro, examination of earlier
timepoints would have been informative. Observation of histone methylation at
timepoints demonstrating the loss of H3K9me3 and subsequent expression of

H3K27me3 would be ideal. Capturing these timepoints would clarify the initial

expression levels H3K27me3, so that the extent to which the histone modification
is fully upregulated could be determined. Regardless, our data suggests
correlation at the cellular level between the onset of BLIMP 1 and H3K27me3

levels which support epigenetic patterns in the mouse model and confirms the

evolutionary conservation of germline epigenetic reprogramming. To our
knowledge the correlation of BL1MP1 and H3K27me3 levels is the first indication

of an epigenetic role for BLIMP1.
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